# Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.

> **NCT01956929** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Insulin Resistance
- Prediabetic State

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01956929
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956929, "Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01956929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*